Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Ethyl p-methoxycinnamate from Kaempferia galanga inhibits angiogenesis through tyrosine kinase

Universa Medicina · Vol. 34 No. 1 (2015) · hlm. 43–51

DOI
10.18051/UnivMed.2015.v34.43-51
ISSN
2407-2230, 1907-3062
Terbit
2015-04-26
Penerbit
Faculty of Medicine, Universitas Trisakti
Bahasa
eng

Abstrak

BACKGROUNDMany tumors express on their receptor tyrosine kinases vascular endothelialgrowth factor activity associated with angiogenesis. Inhibition ofangiogenesis through reduction of tyrosine kinase activity is a promisingstrategy for cancer therapy. The present study aimed to determine themechanism and potency of ethyl p-methoxycinnamate (EPMC) isolatedfrom Kaempferia galanga as angiogenesis inhibitor.METHODSA laboratory experimental study was conducted using chorio-allantoicmembranes (CAMs) of nine-day old chicken eggs induced by 60ng basicfibroblast growth factor (bFGF). Ethyl p-methoxycinnamate (EPMC) potencywas determined at dosages of 30, 60, 90 and 120 μg and compared withcelecoxib 60 μg as reference drug and one negative bFGF-induced controlgroup. Neovascularization and endothelial cell count in CAM blood vesselswere evaluated. To predict the antiangiogenic mechanism of EPMC, adocking study was performed with the Molegro Virtual Docker program ontyrosine kinase as receptor (PDB 1XKK).RESULTSAngiogenesis stimulation by bFGF was prevented significantly (p<0.05)by EPMC at dosages of 30, 60, 90 and 120 μg and this activity was dosedependent. Molecular docking showed interaction between EPMC functionalgroups and tyrosine kinase amino acids at Met766, Met793, Thr854, Thr790,Gln791 and Ala743. There was an association between EPMCantiangiogenic activity and docking study results.CONCLUSIONSEthyl p-methoxycinnamate is a potential new angiogenesis inhibitor throughinteraction with tyrosine kinase. EPMC could be a promising therapeuticagent for treatment of angiogenesis-related diseases.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 164 tautan kepenulisan bersama · 5 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Universitas Hang Tuah
  • Hoshi University
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Maya Nurwartanti YunitaUniversitas Airlangga9
Ratih Novita PrajaUniversitas Airlangga8
Aditya YudhanaUniversitas Airlangga6
Prima Ayu WibawatiUniversitas Airlangga6
Amung Logam SaputroUniversitas Airlangga4
Siswandono SiswandonoUniversitas Airlangga4
Ragil Angga PrastiyaUniversitas Airlangga3
Nusdianto TriakosoUniversitas Airlangga3
Jola RahmahaniUniversitas Airlangga3
Kholis Amalia NofiantiUniversitas Airlangga3
Marcellino RudyantoUniversitas Airlangga2
Ira Sari YudaniayantiUniversitas Airlangga2
Wiwiek TyasningsihUniversitas Airlangga2
Hani PlumeriastutiAfiliasi tidak diketahui2
Arimbi ArimbiUniversitas Airlangga2
IsnaeniAfiliasi tidak diketahui1
Noor Erma NasutionAfiliasi tidak diketahui1
SugijantoAfiliasi tidak diketahui1
Hadi PoerwonoUniversitas Airlangga1
SiswandonoAfiliasi tidak diketahui1
Achmad SyahraniAfiliasi tidak diketahui1
SuzanaAfiliasi tidak diketahui1
Widji SoeratriAfiliasi tidak diketahui1
Dewi IsadiartutiUniversitas Airlangga1
Maria Lucia Ardhani Dwi LestariUniversitas Airlangga1
Dra. Noorma RositaAfiliasi tidak diketahui1
I Gusti Ayu Adhi AryapatniAfiliasi tidak diketahui1
Tristiana ErawatiAfiliasi tidak diketahui1
Herra StudiawanAfiliasi tidak diketahui1
Virnanda Syafira HartatiningrumAfiliasi tidak diketahui1
Rina AndayaniUniversitas Hang Tuah1
Yuseni Kusuma P.Universitas Airlangga1
Retno BijantiUniversitas Airlangga1
Bimo AksonoUniversitas Airlangga1
Sukardiman -Afiliasi tidak diketahui1
Shigeru SasakiHoshi University1
Tutuk BudiatiUniversitas Airlangga1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://univmed.org/ejurnal/index.php/medicina/oai, pertama di-harvest 10 Nov 2026, terakhir terlihat 10 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Ethyl p-methoxycinnamate from Kaempferia galanga inhibits angiogenesis through tyrosine kinase</dc:title>
	<dc:creator xml:lang="en">Ekowati, Juni</dc:creator>
	<dc:creator xml:lang="en">Hardjono, Suko</dc:creator>
	<dc:creator xml:lang="en">Hamid, Iwan Sahrial</dc:creator>
	<dc:subject xml:lang="en">Ethyl p-methoxycinnamate</dc:subject>
	<dc:subject xml:lang="en">chorio-allantoic membrane</dc:subject>
	<dc:subject xml:lang="en">angiogenesis</dc:subject>
	<dc:subject xml:lang="en">tyrosine kinase</dc:subject>
	<dc:description xml:lang="en">BACKGROUNDMany tumors express on their receptor tyrosine kinases vascular endothelialgrowth factor activity associated with angiogenesis. Inhibition ofangiogenesis through reduction of tyrosine kinase activity is a promisingstrategy for cancer therapy. The present study aimed to determine themechanism and potency of ethyl p-methoxycinnamate (EPMC) isolatedfrom Kaempferia galanga as angiogenesis inhibitor.METHODSA laboratory experimental study was conducted using chorio-allantoicmembranes (CAMs) of nine-day old chicken eggs induced by 60ng basicfibroblast growth factor (bFGF). Ethyl p-methoxycinnamate (EPMC) potencywas determined at dosages of 30, 60, 90 and 120 μg and compared withcelecoxib 60 μg as reference drug and one negative bFGF-induced controlgroup. Neovascularization and endothelial cell count in CAM blood vesselswere evaluated. To predict the antiangiogenic mechanism of EPMC, adocking study was performed with the Molegro Virtual Docker program ontyrosine kinase as receptor (PDB 1XKK).RESULTSAngiogenesis stimulation by bFGF was prevented significantly (p&amp;lt;0.05)by EPMC at dosages of 30, 60, 90 and 120 μg and this activity was dosedependent. Molecular docking showed interaction between EPMC functionalgroups and tyrosine kinase amino acids at Met766, Met793, Thr854, Thr790,Gln791 and Ala743. There was an association between EPMCantiangiogenic activity and docking study results.CONCLUSIONSEthyl p-methoxycinnamate is a potential new angiogenesis inhibitor throughinteraction with tyrosine kinase. EPMC could be a promising therapeuticagent for treatment of angiogenesis-related diseases.</dc:description>
	<dc:publisher xml:lang="en">Faculty of Medicine, Universitas Trisakti</dc:publisher>
	<dc:date>2015-04-26</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://univmed.org/ejurnal/index.php/medicina/article/view/49</dc:identifier>
	<dc:identifier>10.18051/UnivMed.2015.v34.43-51</dc:identifier>
	<dc:source xml:lang="en">Universa Medicina; Vol. 34 No. 1 (2015); 43-51</dc:source>
	<dc:source>2407-2230</dc:source>
	<dc:source>1907-3062</dc:source>
	<dc:source>10.18051/UnivMed.2015.v34.i1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://univmed.org/ejurnal/index.php/medicina/article/view/49/431</dc:relation>
	<dc:relation>10.18051/univmed.v34i1.49</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2016 Juni Ekowati, Suko Hardjono, Iwan Sahrial Hamid</dc:rights>
</oai_dc:dc>